WCWildor Samir Cubas

Wildor Samir Cubas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wildor Samir Cubas has a total of 157 co-authors. Here are the top co-authors by number of shared publications:

  • Michael Wayne Art Chu

    Division of Cardiac Surgery, Department of Surgery, Western University, London Health Sciences Centre, ON, Canada

    5 shared publications
  • Carolina Sosa Vota

    Cardiac Surgery National Institute, Montevideo, Uruguay

    4 shared publications
  • Félix Tipacti-Rodríguez

    Service of Vascular and Endovascular Surgery, Department of Thoracic and Cardiovascular Surgery, Edgardo Rebagliati Martins National Hospital, Lima, Peru

    4 shared publications
  • Gerardo Soca

    Cardiac Surgery National Institute, Montevideo, Uruguay

    4 shared publications
  • Joaquín Gundelach

    Department of Cardiac Surgery, Las Higueras Hospital, Talcahuano, Chile

    4 shared publications
  • Santiago Cubas

    Cardiac Surgery National Institute, Montevideo, Uruguay

    4 shared publications

Latest Publications

  • Open Access

    Comparative Long-Term Outcomes of Subcoronary Versus Full-Root Techniques in the Ross Procedure: A Meta-Analysis and Meta-Regression

    by W. Samir Cubas, Joaquín Gundelach, Ace Alfabeto, Yasuhiko Kawaguchi, Michael W.A. Chu

    Objective: The Ross procedure has demonstrated excellent results across various techniques. This meta-analysis compares subcoronary (SC) and full-root (FR) techniques, assessing long-term autograft failure, reintervention, and mortality to compare each approach and durability. Methods: A literature search in PubMed, Embase, Scopus, and Cochrane identified studies (1970 to 2025) comparing SC versus FR Ross techniques with a minimum follow-up of 1 year. A random-effects meta-analysis assessed mortality, autograft failure, and reintervention. Meta-regression evaluated study-level covariate impact on long-term outcomes and durability. Results: Five observational studies were included (2,064 patients; 1,118 SC, 946 FR) with a mean age of 22.7 years and 12.8-year follow-up. SC patients were slightly older and had more congenital heart disease. FR was associated with longer cardiopulmonary bypass and cross-clamp times, with no differences in gender, valve morphology, or New York Heart Association class. Outcomes were comparable for mortality (relative risk [RR] = 0.95, 95% confidence interval [CI]: 0.72 to 1.25), reintervention (RR = 1.02, 95% CI: 0.42 to 2.46), and autograft failure (RR = 0.90, 95% CI: 0.36 to 2.23; hazard ratio = 0.88, 95% CI: 0.63 to 1.24). Meta-regression identified age and prior infective endocarditis as predictors of mortality, whereas longer follow-up modestly reduced reintervention risk, suggesting durable autograft performance or competing risks over time. Conclusions: This meta-analysis reveals comparable long-term outcomes between Ross procedure techniques. It likely reflects surgical expertise and preference, suggesting the approach should be patient tailored, as neither proves superior. Further research is needed to optimize individualized strategies.

  • From legacy to future: A global bibliometric analysis of the Ross procedure over 60 years

    by W Samir Cubas, Ace Alfabeto, Yasuhiko Kawaguchi, Lin-Rui Guo, Michael Wa Chu

    Background: The Ross procedure, introduced in 1967, transformed cardiac surgery. This study presents one of the first global bibliometric analyses, to the best of our knowledge, mapping research trends, collaborations, and authorship to identify future directions in this field. Methods: A global bibliometric analysis of Ross procedure publications (1967–2025) was performed using Scopus and PubMed. Data processed in R (bibliometrix, biblioshiny) explored productivity, collaborations, authorship, and thematic evolution. Future publication trends to 2050 were forecast using a linear extrapolation model with 95% confidence intervals. Results: A total of 2370 Ross procedure publications were identified (1967–2025), showing an 8.1% average annual growth rate. Original articles dominated (65%), followed by reviews/meta-analyses (13.9%) and case reports (13.5%). Among 6228 authors (69.5% male), collaboration averaged 4.9 coauthors/document, with 12.6% international partnerships. The USA (32.3%), the Netherlands (19.3%), and Germany (14.5%) led in productivity. Top institutions were Erasmus University Medical Center (4.3%), Mount Sinai Health System (3.0%), and University Heart Center Lübeck (2.2%). Major journals included Annals of Thoracic Surgery (13.5%), Journal of Thoracic and Cardiovascular Surgery (12.2%), and European Journal of Cardio-Thoracic Surgery (7.6%). Faculty surgeons authored 66% of first-author papers. Main research themes involved allograft reintervention, durability, suture technique, failure, and postoperative complications. Linear regression predicted 164 annual publications by 2050. Conclusions: This analysis reveals an exponentially increasing and sustained global interest in the Ross procedure, which continues to shape cardiac surgery worldwide. The findings highlight growing research output, robust international collaboration, and a focus on clinical innovation, ensuring ongoing advancements in surgical techniques, patient outcomes, and global cardiovascular surgical excellence.


  • Open Access

    Machine learning predicts postoperative mortality in a Latin American cardiovascular surgery multicenter cohort: Toward precision risk stratification

    by W. Samir Cubas, Joaquín Gundelach, Lorena Montes, Maximiliano Hernández, Santiago Cubas, Carolina Sosa Vota, Juan Montero, Gerardo Soca, Víctor Dayán, Michael W.A. Chu


  • Open Access

    Mapping surgical deserts of cardiovascular training in Latin America: A geospatial and structural analysis

    by Wildor Samir Cubas, Joaquín Gundelach, Lorena Montes, Maximiliano Hernández, Santiago Cubas, Carolina Sosa Vota, Juan Andrés Montero, Gerardo Soca, Víctor Dayan, Michael W.A. Chu

  • Open Access

    Preparing for International Cardiovascular Surgery Fellowships: Ten Key Recommendations

    by W. Samir Cubas, Joaquín Gundelach, Paola Keese Montanhesi, Satoshi Arimura, Michael W.A. Chu


  • Open Access

    Sarcoma sinovial pleuropulmonar: reporte de una entidad inusual en un hospital peruano

    by Mayra Aurelia Valderrama Saldaña, Max Almanzor Small, Wildor Samir Cubas Llalle, José René Somocursio Peralta

    Primary pulmonary synovial sarcoma (SS) is a tumor derived from pluripotential mesenchymal cells. It accounts for 0.1-0.5% of all pulmonary tumors and typically occurs in young, non-smoking individuals, classified according to the cellular pattern as monophasic or biphasic. Intrathoracic involvement can occur in various locations, including the pleuropulmonary region, mediastinum, thoracic wall, trachea, and diaphragm. Diagnosis is challenging and treatment includes surgery, chemotherapy, and radiotherapy. We present the case of a 65-year-old male patient with no smoking history who was admitted due to progressive dyspnea, chest pain, and weight loss. Thoracic computed tomography revealed moderate pleural effusion associated with a heterogeneous mass in the left hemithorax. Histopathology of the tissue obtained by percutaneous biopsy reported a primarily monophasic synovial sarcoma. Palliative treatment with serial pleural drainage, chemical pleurodesis, and pain management was indicated. The patient passed away 10 months after the onset of symptoms.

  • Open Access

    Are Homografts Superior to Prosthetic Valves in Destructive Aortic Endocarditis? A Systematic Review and Pairwise Meta‐Analysis of Early–Midterm Outcomes

    by W. Samir Cubas, Joaquín Gundelach, Satoshi Arimura, Ace Alfabeto, Yasuhiko Kawaguchi, Jonathan Hong, Lin-Rui Guo, Michael W. A. Chu

    Background: Destructive aortic endocarditis (DAE) requires complex surgery. Homografts are traditional gold standards, but emerging evidence questions their superiority over prosthetic valves. This systematic review and pairwise meta‐analysis compare early–midterm outcomes. Methods: A comprehensive search of PubMed, Embase, Scopus, and Cochrane (1990–2025) identified studies comparing homografts, mechanical, and bioprosthetic valves for DAE. Outcomes included mortality, reoperation, stroke, reinfection, and midterm survival. Pairwise meta‐analysis and Pearson’s correlation were applied. Results: Sixteen studies (9948 patients) were included (homograft n = 1359; mechanical n = 2717; biological n = 5872). The mean age was 53.5 years, and 74.9% were male. No significant differences were observed in 30‐day mortality (homograft vs mechanical: OR 1.31, 95% CI 0.99–1.72; vs biological: OR 1.15, 95% CI 0.73–1.81), midterm survival (RR 1.00, 95% CI 0.92–1.09; RR 1.06, 95% CI 0.88–1.28), or reinfection (homograft vs mechanical: RR 0.99, 95% CI 0.82–1.19; vs biological: RR 0.77, 95% CI 0.44–1.36). Reoperation was significantly higher with homografts versus mechanical (OR 1.58, 95% CI 1.17–2.14) and biological valves (OR 1.45, 95% CI 1.22–1.72), with no heterogeneity ( I 2 = 0%). Stroke risk was comparable across all comparisons, with nonsignificant numerical trends favoring homografts: homograft vs mechanical (OR 0.86, 95% CI 0.37–1.20), homograft vs biological (OR 0.65, 95% CI 0.30–1.41), and mechanical vs biological (OR 0.99, 95% CI 0.80–1.23). Unadjusted pooled proportions suggested higher early mortality with homografts (19.1%) compared to mechanical (16.8%) and biological (15.1%) valves, though these differences were not statistically significant in adjusted pairwise meta‐analyses. Conclusion: Homografts do not demonstrate definitive superiority for DAE. While nonsignificant numerical trends toward lower stroke rates were observed with homografts, no statistically significant benefits were confirmed for mortality, reinfection, or midterm survival. Homografts were associated with significantly higher reoperation rates without a survival advantage. Valve selection requires patient‐tailored balancing of infection control, durability, and procedural risk.

  • Open Access

    The Evolution of Minimally Invasive Cardiac Surgery Literature: A 50‐Year North American Bibliometric Review and Future Trends

    by Samir Cubas W., Ace Alfabeto, Yasuhiko Kawaguchi, Lin-Rui Guo, Michael W. A. Chu

    Objective: This study provides the first bibliometric analysis of minimally invasive cardiac surgery (MICS) in North America, mapping its evolution, collaboration networks, and research trends while forecasting future scientific trajectories through 2050. Methods: We performed a bibliometric analysis of North American MICS literature (1975–2025) using Scopus and PubMed. Data processed using R (bibliometrix and biblioshiny) enabled network mapping, keyword analysis, and predictive modeling. Metrics included publication growth, document types, authorship, collaboration, citations, h‐index, journals, and research topics. Collaboration networks and thematic evolution were visualized. Future MICS output (2030–2050) was forecasted using linear extrapolation with 95% confidence intervals. Results: We analyzed 1433 publications (United States: 76.3%; Canada: 23.7%). Original articles comprised 48.7%, and case reports comprised 28.7%, with an 8.51% annual growth rate. Among 4800 authors, 89.9% were male, averaging 5.65 coauthors per paper and 22.2% international collaborations. First authors were mainly faculty–surgeons (67.5%) and fellows (15.3%). Top topics are mitral valve (41.7%) and CABG (28.7%). Leading journals are Innovations (16.0%), Annals of Thoracic Surgery (12.6%), Journal of Cardiac Surgery (5.7%), and JTCVS (5.0%). Key affiliations are Cleveland Clinic (13.8%) and Western University (12.5%). Collaborations were strongest with Italy (43.5%) and Germany (32.8%). Forecasting models predicted an annual output of 79 publications by 2030, 93 by 2040, and 107 by 2050 (95% CI 58–146). Conclusions: This inaugural bibliometric analysis of North American MICS outlines five decades of growth, projects continued expansion to 2050, and offers a strategic foundation for future research, funding, and collaboration.